Cartesian Therapeutics (RNAC) EBT Margin Growth (3y) (2018 - 2026)
Cartesian Therapeutics (RNAC) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cartesian Therapeutics | 226.07 Mn | 226.07 Mn | - | -3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.38 Mn |
| Dec 31, 2025 | -797,889.00 |
| Mar 31, 2025 | -186,520.00 |
| Dec 31, 2024 | 298,354.00 |
| Jun 30, 2024 | -5,318.00 |
| Mar 31, 2024 | -35,472.00 |
| Dec 31, 2023 | -224,987.00 |
| Sep 30, 2023 | 7,199.00 |
| Dec 31, 2022 | 21,033.00 |
| Jun 30, 2022 | 12.80 Mn |
| Mar 31, 2022 | 12.25 Mn |
| Dec 31, 2021 | 169,649.00 |
| Dec 31, 2020 | 11.16 Mn |
| Sep 30, 2020 | 5.21 Mn |
| Dec 31, 2019 | 30,884.00 |
| Jun 30, 2019 | -12.76 Mn |
| Mar 31, 2019 | -12.22 Mn |
| Dec 31, 2018 | -132,521.00 |